DEUTSCHE BANK AG\ - IMMUNE PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

IMMUNE PHARMACEUTICALS INC's ticker is IMNPQ and the CUSIP is 45254C200. A total of 13 filers reported holding IMMUNE PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of IMMUNE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$0–40.0%0.00%–
Q4 2017$0–40.0%0.00%–
Q3 2017$0
-100.0%
4
-99.8%
0.00%–
Q2 2017$6,000–2,104–0.00%–
 Download
Other shareholders
IMMUNE PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Intellectus Partners, LLC 31,082$2,0000.00%
View complete list of IMMUNE PHARMACEUTICALS INC shareholders